Page last updated: 2024-09-04
tezosentan and eptifibatide
tezosentan has been researched along with eptifibatide in 1 studies
Compound Research Comparison
Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) | Studies (eptifibatide) | Trials (eptifibatide) | Recent Studies (post-2010) (eptifibatide) |
---|---|---|---|---|---|
157 | 29 | 33 | 907 | 220 | 212 |
Protein Interaction Comparison
Protein | Taxonomy | tezosentan (IC50) | eptifibatide (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.226 | |
Integrin alpha-IIb | Homo sapiens (human) | 0.226 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Other Studies
1 other study(ies) available for tezosentan and eptifibatide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |